SpaceX IPO is the biggest IPO in stock market history. Join the conversation.Click here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksHardide Regulatory News (HDD)

Share Price Information for Hardide (HDD)

Share Price is delayed by 15 minutes
Get Live Data
60.00    0.50 (0.84%)
Bid:
59.00
Ask:
61.00
Spread: 2.00 (3.39%)
Market Cap: £47.29m
HDD Live PriceLast checked at - London Stock Exchange

Intraday Hardide Share Chart

Board Changes

3 Dec 2024 07:00

RNS Number : 5000O
Hardide PLC
03 December 2024
 

The information contained within this announcement is deemed by Hardide to constitute inside information pursuant to Article 7 of EU Regulation 596/2014 as it forms part of UK domestic law by virtue of the European Union (Withdrawal) Act 2018 as amended. 

 

3 December 2024

 

Hardide plc

("Hardide", "the Group" or "the Company")

 

Appointment of Dr. Bryan Allcock as an Independent Non-Executive Director

 

Hardide plc, the provider of advanced surface treatment solutions, is pleased to announce the appointment of Dr. Bryan Allcock to the Board today as an Independent Non-Executive Director. Bryan will succeed Tim Rice as Hardide's Senior Independent Director and Chair of the Remuneration Committee with effect from 1 January 2025, as Tim will be stepping down from the Board on 31 December 2024.

 

Bryan has career long experience working in the advanced materials, surface engineering and coatings industry.

 

He is currently CEO of his own business, TRL9 Limited, which runs a portfolio of research, development and deployment projects, including the use of high entropy alloys. Bryan acts as a subject matter expert to the Ministry of Defence and BAE Systems for the coating of flight decks for Queen Elizabeth Class aircraft carriers and has collaborative research contracts with Jaguar Land Rover, the Defence and Security Accelerator (DASA) and the European Space Agency.

 

Bryan was formerly Global CEO for the Services business of Castolin Eutectic Limited, part of the Messer Group, where he ran an international £56m revenue business delivering surface engineering and advanced coating solutions. Bryan joined Castolin Eutectic having sold his own business, Monitor Coatings, to them in 2013.

 

Bryan spent his earlier career as Head of Technical Services at Flight Refuelling Limited, part of Cobham plc, where he grew profits significantly through business development of the coatings division, operational improvement and efficiency initiatives.

 

Bryan holds an MBA, has a degree in applied chemistry and materials, and holds a PhD in Corrosion Engineering from Cranfield University. He is a fellow of the Institute of Materials, Minerals and Mining and has been a strategic advisor to the Institute.

 

Further information regarding Bryan Allcock, as required by Schedule 2(g) of the AIM Rules for Companies, is set out below.

 

Andrew Magson, Non-Executive Chair, commented:

 

"We are delighted that Bryan is joining the Hardide Board. He has a deep understanding of the coatings and surface treatment sectors and a rare combination of technical, business development, sales and marketing skills. Together with an entrepreneurial mind-set, this means his knowledge and experience is highly aligned with Hardide's strategy of better commercialising the business and accelerating revenue growth.

 

I'd also like to place on record the Board's thanks to Tim Rice, who has provided wise counsel to all of us during his six years of service as our Senior Independent Director. Tim was instrumental to Hardide's success in developing its business with the aerospace sector. We wish him well for the future."

 

 

Dr. Bryan Allcock BSc (Hons) PhD, MBA, FIMMM (Age 57)

 

Current Directorships:

 

TRL9 Limited

Solar Fluidics UK Limited

Burgham Park Residents Association Limited

Zonne Limited

UVCR Limited

 

Past Directorships in the last 5 years:

 

None.

 

Bryan Allcock does not own any ordinary shares or options over ordinary shares in the Company.

 

There is no further information on Bryan Allcock required to be disclosed under Schedule Two, paragraph (g) of the AIM Rules for Companies.

 

 

 

For further information:

Hardide plc

Andrew Magson (Non-Executive Chair)

Tim Rice (Senior Independent Director)

Matt Hamblin (CEO)

 

Tel: +44 (0) 1869 353 830

 

 

 

Cavendish Capital Markets Ltd - Nominated Adviser and Broker

Henrik Persson/ Abigail Kelly / Elysia Bough (Corporate Finance)

Jasper Berry / Dale Bellis (Sales)

 

Tel: +44 (0) 2072 200 500

 

Notes to editors:

www.hardide.com

 

Hardide develops, manufactures and applies advanced technology tungsten carbide/tungsten metal matrix coatings to a wide range of engineering components. Its patented technology is unique in combining in one material, a mix of toughness and resistance to abrasion, erosion and corrosion; together with the ability to coat accurately interior surfaces and complex geometries. The material is proven to offer dramatic improvements in component life, particularly when applied to components that operate in very aggressive environments. This results in cost savings through reduced downtime and increased operational efficiency as well as a reduced carbon footprint. Customers include leading companies operating in the energy sectors, valve and pump manufacturing, industrial gas turbine, precision engineering and aerospace industries.

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
BOAFLFITFSLFIIS
Date   Source Headline
1st Jun 20263:35 pmRNSHolding(s) in Company
27th May 20267:00 amRNSSignificant further order intake North America
21st May 20267:00 amRNSInterim Statement
5th May 20266:00 pmRNSHolding(s) in Company
28th Apr 20267:00 amRNSNew Order Intake and Notice of Interim Results
24th Mar 20264:30 pmRNSResult of AGM
24th Mar 20264:22 pmRNSHolding(s) in Company
24th Mar 20267:00 amRNSAGM Trading Statement
20th Mar 20265:05 pmRNSHolding(s) in Company
17th Mar 20267:00 amRNSNotice of AGM
17th Mar 20267:00 amRNSNotice of AGM
11th Mar 202610:09 amRNSHolding(s) in Company
11th Mar 202610:09 amRNSHolding(s) in Company
26th Feb 20267:00 amRNSFurther significant North American order intake
13th Feb 202612:03 pmRNSHolding(s) in Company
11th Feb 202611:35 amRNSDirector Dealings
10th Feb 202612:48 pmRNSGrant of Executive Share Options
3rd Feb 20267:00 amRNSSignificant New Order in North America
29th Jan 202611:17 amRNSHolding(s) in Company
22nd Jan 20267:00 amRNSAnnual results to 30 September 2025
12th Jan 20267:00 amRNSNotice of Results
1st Dec 20253:03 pmRNSHolding(s) in Company
1st Dec 20257:00 amRNSSignificant Orders from a Major New Customer
7th Nov 20258:53 amRNSHolding(s) in Company
24th Oct 20255:20 pmRNSDirector/PDMR Shareholding
22nd Oct 20257:00 amRNSYear End Trading Update
28th May 20253:00 pmRNSDirector Dealings
27th May 20252:48 pmRNSDirector Dealings
20th May 20257:00 amRNSInterim Statement
18th Mar 20253:30 pmRNSResult of AGM
18th Mar 20257:00 amRNSAGM Trading Statement
4th Feb 20257:00 amRNSDirector Dealings
29th Jan 20257:00 amRNSAnnual results for year ended 30 September 2024
15th Jan 202510:00 amRNSNotice of Results
27th Dec 20247:00 amRNSGrant of Options and Issue of Shares
18th Dec 20247:00 amRNSNew Aerospace Supply Agreement
3rd Dec 20247:00 amRNSBoard Changes
21st Oct 20247:00 amRNSYear End Trading Update
18th Jun 20247:00 amRNSBoard Change and Appointment of Sole Broker
22nd May 20247:01 amRNSInterim Statement
22nd May 20247:00 amRNSAnnouncement of new Chief Executive Officer
8th May 20247:00 amRNSNotice of Results
1st May 202410:27 amRNSHolding(s) in Company
18th Apr 20245:40 pmRNSHolding(s) in Company
26th Mar 20247:00 amRNSLaunch of Ready Coated Component Range
25th Mar 20241:06 pmRNSResult of AGM
25th Mar 20247:00 amRNSAGM Statement
12th Mar 20242:57 pmRNSHolding(s) in Company
6th Mar 20245:10 pmRNSHolding(s) in Company
5th Mar 20243:02 pmRNSBoard Update

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.